In diabetes treatment, DPP4 inhibitors have been a vital focus, but now, there’s a fresh perspective on microbial DPP4. Let’s explore this emerging concept, its implications, and potential advancements in type 2 diabetes management.
INCRETIN-BASED THERAPIES
While the anti-diabetic therapies majorly include insulin secretagogues and insulin sensitizers, important advancements have occurred in the last few years in the field of diabetes treatment. The priority in the therapy of patients with diabetes is not only glycemic control per se but it now includes an overall management of risk factors with individualization of glycemic target.
The drugs which are used as second line agents (after metformin) in the therapeutic algorithm of type 2 diabetes mostly represented by the incretin-based therapies. This includes glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase 4 (DPP-4) inhibitors.
DPP4 INHIBITOR ADVANTAGE
This story is from the January 2024 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the January 2024 edition of Healthcare Radius.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Are You Sleeping Enough, Doctor?
In this engaging conversation, we delve into the world of sleep with Dr Prashant Makhija, Consultant Neurologist, Wockhardt Hospital, Mumbai Central. Dr Prashant sheds light on the often overlooked aspect of healthcare–the sleep health of doctors. With a compassionate understanding of the challenges faced by the Indian doctors, he advocates for sleep equity, ensuring that our healthcare heroes are at their best for themselves and their patients.
Will India Eradicate Malaria By 2027?
India's ambitious malaria eradication goal faces a few hurdles despite progress made and the industry efforts.
Medikabazaar opens CDC in Kolkata
Medikabazaar, a B2B online healthcare platform, has inaugurated a new Central Distribution Center CDC) in Kolkata.
Alcon unveils Clareon IOLs in India
Global eye care player Alcon launches Clareon family of intraocular lenses IOLs) in India.
USV opens plant in Himachal Pradesh
To manufacture cardiology targeted medicine products at the new plant.
A RAY OF HOPE FOR HEART PATIENTS
Faced with severe heart failure, an 84-year-old gets a fresh lease of life due to Impella, a tiny device. Learn how Impella is changing patient lives in India.
R+CU'S CANCER TREATMENT PROMISE: HOPE OR HYPE?
Tata Memorial Center’s proposed cancer pill claims to tackle recurrence, but human trials are needed for confirmation, says the author.
BRIDGING THE KIDNEY TRANSPLANTS GAP
Explore the current landscape, including breakthroughs, access barriers, and promising future directions for kidney transplantation in modern India.
Wockhardt runs women empowerment campaign
Wockhardt Hospitals concludes International Women’s Day 2024 celebrations with “I am Fearless” campaign promoting women empowerment.
Feminine hygiene and cervical cancer awareness drive unveiled
CARE Hospitals launches Tejaswini, a CSR initiative focusing on feminine hygiene and cervical cancer awareness for girls in Hyderabad